Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory Effort

June 8, 2026 updated by: Jingyuan,Xu
This study explored how inspiratory effort affects the accuracy of the distensibility index of inferior vena cava (dIVC) in assessing fluid responsiveness (FR).This prospective observational study was conducted in an intensive care unit of a university hospital and included shock patients receiving ventilation with spontaneous breathing activity. Hemodynamic parameters were collected before and after fluid challenge by the pulse indicator continuous cardiac output. dIVC was calculated by ultrasound, and respiratory effort was assessed using airway occlusion pressure (P0.1) and end-expiratory occlusion pressure (Pocc) before fluid administration. Responders were defined by a ≥10% increase in cardiac output (CO) after 250 mL saline infused in 10 minutes. The dIVC > 18% was considered indicative of FR. Predictive performance was evaluated using area under receiver operating characteristic curves (AUROC), stratified by P0.1 and Pocc.

Study Overview

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China
        • Zhongda hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

This prospective observational study was conducted in an intensive care unit of a university hospital and included shock patients receiving ventilation with spontaneous breathing activity

Description

Inclusion Criteria:

  1. defined as shock who has the presence of systolic blood pressure (SBP) ≤ 90 or a > 40 mmHg decline of SBP in patients known to be hypertensive or mean arterial pressure (MAP) ≤ 70 mmHg or requiring vasopressors to maintain SBP > 90 mmHg or MAP > 70 mmHg, along with signs of hypoperfusion (urinary flow < 0.5 ml/kg/min for > 2 h, or presence of skin mottling or blood lactate concentration ≥ 2.0 mmol/L);
  2. received mechanical ventilation;
  3. had the Pulse Indicator Continuous Cardiac Output (PiCCO) catheter for hemodynamic monitoring;
  4. had the sign of fluid administration which include: (a) MAP < 65 mmHg and/or SBP < 90 mmHg; (b) the need for vasopressors; (c) urinary flow < 0.5 ml/kg/min for >2 h; (d) tachycardia; (e) lactic acidosis; or (f) delayed capillary refilling.

Exclusion Criteria:

  1. were pregnant;
  2. were younger than 18 years of age;
  3. could not have spontaneous respiratory drive or effort measured;
  4. had intra-abdominal pressure ≥ 16 cmH₂O [15];
  5. had conditions affecting dIVC measurement, such as ECMO cannulation;
  6. had factors precluding clear ultrasound imaging;
  7. defined as right ventricular dysfunction who has (a) tricuspid annular plane systolic excursion < 16 mm; (b) moderate or greater tricuspid regurgitation; (c) moderate or greater pulmonary artery hypertension[16];
  8. expected to die within 24 hours;
  9. had family members of the patient declined enrollment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
inspiratory effort affects the accuracy of the distensibility index of inferior vena cava in assessing fluid responsiveness
Time Frame: immediate
immediate

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Actual)

March 31, 2025

Study Completion (Actual)

May 31, 2025

Study Registration Dates

First Submitted

June 8, 2026

First Submitted That Met QC Criteria

June 8, 2026

First Posted (Actual)

June 12, 2026

Study Record Updates

Last Update Posted (Actual)

June 12, 2026

Last Update Submitted That Met QC Criteria

June 8, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shock

Subscribe